TABLE 1.
Characteristics of the patients included in this study (n = 117)
| Variables | Mean ± SD, n (%) |
|---|---|
| Age [years] | 42.4 ± 11.5 |
| Gender, male/female | 53 (45.3)/64 (54.7) |
| Admitted, involuntary/voluntary | 103 (88.0)/14 (12.0) |
| Number of hospital admissions | 3.9 ± 3.6 |
| Diabetes mellitus, yes/no | 6 (5.1)/111 (94.9) |
| History of substance use, yes/no | 6 (5.1)/111 (94.9) |
| History of alcohol addiction, yes/no | 12 (10.3)/105 (89.7) |
| PANSS | 88.9 ± 21.8 |
| BPRS | 49.5 ± 14.5 |
| GAF a | 59.4 ± 10.5 |
| SAI‐J a | 15.5 ± 4.0 |
| DAI‐10 a | 4.8 ± 4.9 |
| SCoRS‐J a | 34.1 ± 11.2 |
| Clozapine, yes/no b | 2 (1.7)/115 (98.3) |
| Electro Convulsive therapy, yes/no b | 21 (17.9)/96 (82.1) |
| Long‐acting injection use/not use b | 28 (23.9)/89 (76.1) |
| Chlorpromazine equivalent dose [mg] b | 958.8 ± 565.7 |
| Social resources and support | |
| Members in household, alone/with family b | 60 (51.3)/57 (48.7) |
| Living arrangement, own home/residential care b | 97 (82.9)/20 (17.1) |
| Psychiatric day care, use/not use b | 57 (48.7)/60 (51.3) |
| Community occupational therapy, use/ not use b | 22 (18.8)/95 (81.2) |
| Employment Services, use/not use b | 14 (12.0)/103 (88.0) |
| Psychiatric home‐visit nursing care, use/not use b | 62 (53.0)/55 (47.0) |
Measured at the beginning of psychoeducation.
Abbreviations: BPRS, Brief Psychiatric Rating Scale; DAI‐10, Drug Attitude Inventory‐10 items; GAF, Global Assessment of Functioning; PANSS, Positive and Negative Syndrome Scale; SAI‐J, Schedule for the Assessment of Insight Japanese version; SCoRS‐J, Schizophrenia Cognition Rating Scale Japanese version.
a
Measured at the end of psychoeducation.
b
Measured at discharge.